Immatics (IMTX) Net earnings per share growth forecast for next year

Symbol and logo of brand Immatics Corp (IMTX)

Logistics disruptions and sanctions are temporarily hindering the global trials of Immatics N.V. (IMTX), yet the long-term strategy relies on a hybrid of in-house production and CRO partners. The forward earnings per share trend visualizes this balance, where the -0.90 indicator determines the magnitude of the metric. The ultimate growth of the T-cell therapy ecosystem now depends directly on strict FDA oversight and Big Pharma investments.

IMTX - Immatics Corp Earnings growth forecast for next year over the range 07/04/2022 - 11/14/2026

Metric breakdowns and analytics for Immatics Corp (IMTX)

- price and consensus price forecast:
Price Chart immatics.com|IMTX - Consensus Target
- market capitalization details:
Market Value Immatics Corp|IMTX - Real Price to Acquire Entire Company
- company book value details:
Accounting Value per Share Immatics|IMTX - Book Capitalization|Market Value to Book Value Ratio immatics.com|IMTX - Total Business Assets
- company liabilities and liquidity data:
Debt to Equity Immatics N.V.|IMTX - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Immatics NV|IMTX - Company Total Indebtedness|Debt to Book Value Immatics|IMTX - Amount of Long-Term Liabilities|Company Short-Term Debts Immatics|Quick Ratio immatics.com
- earnings and market ratios statistics:
IMTX - Company Net Income|Expected Profit Immatics N.V.|IMTX - Company Value to Net Income|Forward P/E Multiple immatics.com|IMTX - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Immatics N.V.|IMTX - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share for the last 12 months Immatics|IMTX - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth immatics.com|IMTX - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Immatics N.V.
- revenue and sales proceeds data:
IMTX - Company Sales|Company Projected Revenue immatics.com|IMTX - Market Cap to Revenue|Forward P/S Multiple Immatics N.V.
Analysis of all company metrics:Immatics Corp
Core merchandise of Immatics NV

This indicator measures expected earnings momentum for the upcoming period, reflecting the analysts' consensus forecast regarding the business's ability to generate income. Analyzing the historical trend of n+1 earnings forecasts allows for the separation of speculative noise from fundamental growth, which is critically important for Immatics N.V. (IMTX) in the context of the IMA203 platform's success and strategic payments from global pharmaceutical partners.

Direct competitors

Net earnings per share growth forecast for next year immunitybio.com|Expected earnings per share growth for next year immunocore.com (IMCR)|Net earnings per share growth forecast for next year Janux Therapeutics Inc (JANX)|Expected earnings per share growth for next year Arcus Bio RCUS|Zymeworks Inc - Expected earnings per share growth for next year|Earnings growth forecast for next year Tango Therapeutics Corp TNGX|IOVA - Net earnings per share growth forecast for next year|XNCR (xencor.com) - Projected earnings per share growth rate for next year|Compass Therapeutics Corp (CMPX) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Replimune Corp (REPL)|Expected earnings per share growth for next year LYEL|IPHA - Net earnings per one share growth forecast for next year|Expected earnings per share growth for next year PYXS (Pyxis Oncology, Inc.)|Projected earnings per share increase next year CGEN|Earnings growth forecast for next year IOBT (IO Biotech)|Expected earnings per share trend next year STRO|minktherapeutics.com - Earnings growth forecast for next year|Expected net earnings per share growth next year Werewolf Therapeutics, Inc.|Immix (IMMX) - Net earnings per share growth forecast for next year|ALX Oncology Holdings - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Cue Biopharma|Earnings growth forecast for next year pdsbiotech.com|Net earnings per share growth forecast for next year sonnetbio.com (SONN)|MAIA: Net earnings per share change forecast for next year|Liminatus Pharma Inc. - Expected earnings per share growth for next year|LAVA Therapeutics N.V. (LVTX) - Expected net earnings per share growth next year|NXTC - Net earnings per share growth forecast for next year|LPTX: Net earnings per share growth forecast for next year|Intensity Therapeutics (INTS) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Sensei Bio (SNSE)|TOVX (Theriva Biologics Inc) - Earnings growth forecast for next year|Gritstone bio (GRTS) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year KA|Consensus forecast of earnings per share growth for next year NexImmune Inc|Net earnings per share growth forecast for next year turnstonebio.com TSBX|Consensus forecast of earnings per share growth for next year Vaccinex Inc (VCNX)|HARP - Net earnings per share growth forecast for next year